Building Robust, Standardized Biospecimen Operations Across a Fragmented Global Workflow

Standardize Seamless Biomarker Execution Across Increasingly Complex Trials Through Smarter, Scalable Operational Strategies

For the very first time, the biomarker and biospecimen management community will have a forum solely dedicated to this rapidly expanding and ever-increasingly critical function.

As trials expand globally and become more sample-intensive, protecting sample integrity and turning specimen data into trustworthy decisions has never mattered more. The inaugural Biomarker Operations & Biospecimen Management Summit provides a long-overdue home to share experiences and define the standards this field now demands.

Following the complete sample lifecycle, from kit design and site collection, through to tracking, storage, biobanking, lab coordination and data harmonization, walk away with the real-time insights needed to implement robust, scalable biomarker and biospecimen operations.

Join 80+ fellow senior leaders from biopharma, labs, CROs, and biobanks, in the united mission of ensuring every sample is treated with the precision, rigor and care it requires.

Biomarker operations may work behind the scenes, but every breakthrough begins with and relies on getting the right samples

Head, Oncology Translational Medicine Operations & Experimental Oncology, AstraZeneca, 2026 Speaker

AstraZeneca

I’m excited to be part of this inaugural summit and look forward to collaborating with industry leaders who are passionate about driving innovation, collaboration and operational excellence across the biospecimen management ecosystem

Executive Director & Head, Consent, Biospecimens & Imaging, Bristol Myers Squibb, 2026 Speaker

BMS logo

The Biospecimen Management Consortium was founded on the belief that the biggest challenges in biospecimen management cannot be solved by any one stakeholder alone. I'm excited to continue that conversation with leaders from across the clinical trial ecosystem and explore how collaboration can help move us forward

Founder, Biospecimen Management Consortium (BMC), 2026 Speaker

BMC

Delve into the Full Program to Discover

  • Perspectives from 22+ Expert Speakers from Leading Pharma, Biotech & Consortia Organizations 
  • Real-World Insights from 20+ Case Studies Spanning the Full Sample Lifecycle 
  • Dedicated Networking Opportunities Built to Strengthen & Spark Collaborations 
  • The Complete Session, Panel & Roundtable Details Hyper-Relevant to Every Stakeholder 
  • The Industry's First & Only Dedicated Forum to the Biomarker Operations & Biospecimen Management Community 
Biomarker Operations & Biospecimen Management Summit 2026 Event Guide

What Awaits You at this First-of-Its-Kind Forum

90%

of Sessions Led by Biopharma & Biotech Practitioners

68%

of Attendees at C-Level, VP & Director Level

17+

Pharma Giants & Innovative Biotech Represented on the Agenda

6

Dedicated Presentation Themes Spanning the Full Sample Lifecycle

4+

Interactive, Discussion-Led Roundtables & Panel Sessions

2

Days of Focused Biomarker & Biospecimen
Operations Content

1

Landmark Program
Dedicated to Biomarker &
Biospecimen Management

Biopharma Companies in Attendance Include

Audience at Biomarker Operations & Biospecimen Management Summit

Discover the New Agenda

Hear the latest breakthroughs in biomarker operations and gain exclusive insights across industry-led sessions, interactive BMC roundtables, and discussion-based panels

Audience at Biomarker Operations & Biospecimen Management Summit

Partner With the Future

Position your organization directly alongside the architects of modern biomarker operations to ensure your brand is at the heart of every sample lifecycle decision

Audience at Biomarker Operations & Biospecimen Management Summit

Join Biomarker Stakeholders

Be part of the first forum dedicated to this space, connecting with senior decision-makers from biopharma, central labs, and diagnostics across two action-packed conference days